NCT05996835: An ongoing trial by Novartis Pharmaceuticals
This trial is ongoing. It must report results 10 months, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05996835 |
|---|---|
| Title | A Multicenter, Randomized, Double-blind, Placebo-controlled, Four-arm, Parallel-group, Dose-finding Phase 2b Study to Investigate the Safety and Efficacy of TIN816 Via a Single Intravenous Infusion in the Treatment of Participants With Sepsis-associated Acute Kidney Injury (CLEAR-AKI) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 18, 2024 |
| Completion date | Feb. 25, 2026 |
| Required reporting date | Feb. 25, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |